Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium

PLoS One. 2018 Jun 12;13(6):e0198690. doi: 10.1371/journal.pone.0198690. eCollection 2018.

Abstract

Schizophrenia (SCZ) is a severe psychiatric disorder with evidence of a strong genetic component in the complex etiologies. Some studies indicated that gamma-aminobutyric acid (GABA)A receptor β2 subunit gene (GABRB2) was associated with SCZ. Other studies reported a negative association. Moreover, the results of two previous meta-analyses of GABRB2 with SCZ were inconsistent and the sample sizes were limited. Therefore, an updated meta-analysis combined with genome-wide association study (GWAS) data of the Han Chinese population and Psychiatric Genomics Consortium (PGC) was performed. Available case-control and family-based genetic data were extracted from association studies, and the GWAS data were included. The findings showed no association between six single-nucleotide polymorphisms of GABRB2 (rs6556547, rs1816071, rs1816072, rs194072, rs252944, and rs187269) and SCZ in a total of 51,491 patients and 74,667 controls. The ethnic subgroup analysis revealed no significant association in Asian populations. Since the PGC data of SCZ (SCZ-PGC, 2014) contained 3 studies of Asian populations (1866 patients and 3418 controls), only the data of European samples in SCZ-PGC were used for the meta-analysis of the Caucasian population in the present study. The result still showed no association in the Caucasian population. In conclusion, the present meta-analysis on combined data from GWASs of the Han Chinese population and PGC suggested that GABRB2 polymorphisms might not be associated with SCZ.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • China / epidemiology
  • Databases, Factual
  • Genetic Predisposition to Disease
  • Humans
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Receptors, GABA-A / genetics*
  • Schizophrenia / epidemiology*
  • Schizophrenia / genetics*

Substances

  • GABRB2 protein, human
  • Receptors, GABA-A

Grants and funding

This work was supported by grants from the National Key R&D Program of China (grant numbers: 2016YFC1307000; the URLs: http://www.most.gov.cn; author: Weihua Yue) and the National Natural Science Foundation of China (grant numbers: 81471360; the URLs: http://www.nsfc.gov.cn/; author: Dai Zhang). Weihua Yue involved in data collection and Dai Zhang involved in decision to publish.